A Randomized Controlled Trial of Inhaled Tranexamic Acid for the Treatment of Pulmonary Hemorrhage in Cancer Patients

This is a drug study that will examine if inhaled tranexamic acid can improve mortality in patients with cancer-related pulmonary hemorrhage and respiratory failure as compared to usual care.

Trial Details

NCT ID
NCT05053867
Phase
PHASE3
Sponsor
M.D. Anderson Cancer Center
Status
RECRUITING
Cancer Type
Lung Cancer
Interventions
  • tranexamic acid
  • Usual Care
Locations (sample)
  • Houston, Texas, United States|29.76328,-95.36327

Key Eligibility Criteria

  • Age \> 18 years old
  • Have a diagnosed hematological malignancy
  • Are actively receiving mechanical ventilation
  • Have evidence of pulmonary hemorrhage as defined by either

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Lung Cancer Trials on Trialify →